Menu
Back to User profile » Prof. Dr. Shukui Qin
Papers published by Prof. Dr. Shukui Qin:
Subgroup Analysis by Liver Metastasis in the FRESCO Trial Comparing Fruquintinib versus Placebo Plus Best Supportive Care in Chinese Patients with Metastatic Colorectal Cancer
Qin S, Xu RH, Shen L, Xu J, Bai Y, Yang L, Deng Y, Chen ZD, Zhong H, Pan H, Guo W, Shu Y, Yuan Y, Zhou J, Xu N, Liu T, Ma D, Wu C, Cheng Y, Chen D, Li W, Sun S, Yu Z, Cao P, Chen H, Wang J, Wang S, Wang H, Wang N, Zhang B, Zhang Q, Su W, Guo X, Li J
OncoTargets and Therapy 2021, 14:4439-4450
Published Date: 11 August 2021
Camrelizumab Combined with FOLFOX4 Regimen as First-Line Therapy for Advanced Hepatocellular Carcinomas: A Sub-Cohort of a Multicenter Phase Ib/II Study
Li H, Qin S, Liu Y, Chen Z, Ren Z, Xiong J, Meng Z, Zhang X, Wang L, Zhang X, Zou J
Drug Design, Development and Therapy 2021, 15:1873-1882
Published Date: 3 May 2021
A retrospective six-patient series of apatinib for the treatment of persistent or recurrent carcinoma of the cervix
Chen C, Qin S, Li Z, Luo X, Zhang Y, Zhang J, Liu X
OncoTargets and Therapy 2019, 12:5805-5811
Published Date: 17 July 2019
Afatinib vs erlotinib for second-line treatment of Chinese patients with advanced squamous cell carcinoma of the lung
Lu S, Li W, Zhou C, Hu CP, Qin S, Cheng G, Feng J, Wang J, Cseh A, Peil B, Gibson N, Ehrnrooth E, Zhang L
OncoTargets and Therapy 2018, 11:8565-8573
Published Date: 30 November 2018
Local analgesic effect of a bioadhesive barrier-forming oral liquid in cancer patients with oral mucositis caused by chemotherapy and/or radiotherapy: a randomized multicenter, single-use, positive-controlled, open-label study
Cheng Y, Qin SK, Chen YP, Dong LH, Sun XD, Yu SY, Wu SK
OncoTargets and Therapy 2018, 11:8555-8564
Published Date: 30 November 2018
Treatment with olaparib monotherapy for BRCA2-mutated refractory intrahepatic cholangiocarcinoma: a case report
Cheng Y, Zhang J, Qin SK, Hua HQ
OncoTargets and Therapy 2018, 11:5957-5962
Published Date: 18 September 2018
The synergistic effects of Apatinib combined with cytotoxic chemotherapeutic agents on gastric cancer cells and in a fluorescence imaging gastric cancer xenograft model
Feng JH, Qin SK
OncoTargets and Therapy 2018, 11:3047-3057
Published Date: 24 May 2018
Multiline treatment combining apatinib with toptecan for platinum-resistant recurrent ovarian cancer patients: a report of three cases
Cheng Y, Zhang J, Geng HY, Qin SK, Hua HQ
OncoTargets and Therapy 2018, 11:1989-1995
Published Date: 6 April 2018